Certified by Founder Lodge
adMare BioInnovations
Canada - ND
INVESTOR
1 Disclosed Funding Rounds $142,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Ca
| Company | Date | Round | Raised |
|---|---|---|---|
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 Specific Biologics |
October, 17 ,2023 | Unknown |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Allos | $5,000,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
